Concepedia

Conrad Santini

CS

Statistics

Publications

25

Citations

1.4K

H-Index

18

Active since

1981

Affiliations

University of Kansas(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Baylor College of Medicine

Rice University

York University

Conrad Santini is an author at University of Kansas specializing in medicinal chemistry, pharmacy, and drug discovery.

ORCID

Publications per year

1981–2021

25

Publications

25

Novel Peroxisome Proliferator-activated Receptor (PPAR) γ and PPARδ Ligands Produce Distinct Biological Effects

Joel P. Berger, Mark D. Leibowitz, Thomas W. Doebber et al. · Journal of Biological Chemistry · 1999 · 412 citations · Full text

, , +17

Activation of PPARδ alters lipid metabolism in db/db mice

Mark D. Leibowitz, Catherine Fiévet, Nathalie Hennuyer et al. · FEBS Letters · 2000 · 308 citations · Full text

, , +17

Novel 2,3-Dihydrobenzofuran-2-carboxylic Acids:  Highly Potent and Subtype-Selective PPARα Agonists with Potent Hypolipidemic Activity

Guo Q. Shi, James F. Dropinski, Yong Zhang et al. · Journal of Medicinal Chemistry · 2005 · 101 citations · Full text

, , +14

Cyclobutene bridgehead olefin route to the American cockroach sex pheromone, periplanone-B

Stuart L. Schreiber, Conrad Santini · Journal of the American Chemical Society · 1984 · 88 citations

, , +6

Absolute Stereochemistry of the Squalene Synthase Inhibitor Zaragozic Acid C

Conrad Santini, Richard G. Ball, Gregory D. Berger · The Journal of Organic Chemistry · 1994 · 45 citations

, , +8

1–5 of 25